Science
MD Anderson’s Therapeutics Discovery Division, Orionis Biosciences Launch Project Helios to Advance Novel Small-Molecule Cancer Medicines – Press Release – Digital Journal
Combining Orionis’ unique high-throughput drug discovery technologies with the Therapeutics Discovery division’s expertise in small-molecule therapies and translational…
BOSTON & GHENT, Belgium & HOUSTON–(Business Wire)–Orionis Biosciences, a life sciences company pioneering innovation in genome-scale drug discovery, and The University of Texas MD Anderson Cancer Centers Therapeutics Discovery division today announced the launch of Project Helios, a research collaboration designed to unlock new drug development opportunities through genome-scale mapping of drug-target interactions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210309005121/en/
…
-
Noosa News16 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
General13 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News22 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
Business18 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth